- Home
- RDHL vs PAVM Comparison
RDHL vs PAVM Comparison
Compare RDHL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- PAVM
- Stock Information
- Founded
- RDHL 2009
- PAVM 2014
- Country
- RDHL Israel
- PAVM United States
- Employees
- RDHL N/A
- PAVM N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- RDHL Health Care
- PAVM Health Care
- Exchange
- RDHL Nasdaq
- PAVM Nasdaq
- Market Cap
- RDHL 3.9M
- PAVM 8.0M
- IPO Year
- RDHL N/A
- PAVM 2016
- Fundamental
- Price
- RDHL $1.51
- PAVM $0.42
- Analyst Decision
- RDHL
- PAVM Strong Buy
- Analyst Count
- RDHL 0
- PAVM 1
- Target Price
- RDHL N/A
- PAVM $19.00
- AVG Volume (30 Days)
- RDHL 89.3K
- PAVM 268.2K
- Earning Date
- RDHL 09-05-2025
- PAVM 11-12-2025
- Dividend Yield
- RDHL N/A
- PAVM N/A
- EPS Growth
- RDHL N/A
- PAVM N/A
- EPS
- RDHL N/A
- PAVM 0.83
- Revenue
- RDHL $9,550,000.00
- PAVM $1,020,000.00
- Revenue This Year
- RDHL $381.91
- PAVM N/A
- Revenue Next Year
- RDHL N/A
- PAVM $455.63
- P/E Ratio
- RDHL N/A
- PAVM $0.50
- Revenue Growth
- RDHL 157.62
- PAVM N/A
- 52 Week Low
- RDHL $1.06
- PAVM $0.30
- 52 Week High
- RDHL $11.70
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- RDHL 54.23
- PAVM 39.49
- Support Level
- RDHL $1.22
- PAVM $0.42
- Resistance Level
- RDHL $1.60
- PAVM $0.49
- Average True Range (ATR)
- RDHL 0.08
- PAVM 0.04
- MACD
- RDHL 0.04
- PAVM -0.00
- Stochastic Oscillator
- RDHL 76.32
- PAVM 4.64
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.